Cargando…

The Frequency of Mutations in Exon 11 of the c-kit Gene in Patients With Leukemia

Objective: To determine the frequency of mutations in exon 11 of the c-kit gene in patients with leukemia. Material and Methods: The study included 50 leukemia patients (31 with acute myeloid leukemia, 5 with acutelymphoblastic leukemia, 9 with chronic myeloid leukemia, and 5 with chronic lymphocyti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hussain, Syed Rizwan, Babu, Sunil G, Naqvi, Hena, Singh, Pradyumn, Mahdi, Farzana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986761/ https://www.ncbi.nlm.nih.gov/pubmed/24744618 http://dx.doi.org/10.5505/tjh.2012.60320

Ejemplares similares

Screening of C-kit gene Mutation in Acute Myeloid Leukaemia in Northern India
por: Hussain, SR, et al.
Publicado: (2012)

Mutations in C-KIT exon 11 in canine cutaneous mast cell tumors
por: Neto, Rafael T, et al.
Publicado: (2013)

Canine and human gastrointestinal stromal tumors display similar mutations in c-KIT exon 11
por: Gregory-Bryson, Emmalena, et al.
Publicado: (2010)

Analysis of C-Kit Exon 9, Exon 11 and BRAFV600E Mutations Using Sangers Sequencing in Gastrointestinal Stromal Tumours
por: Madhala, Divya, et al.
Publicado: (2020)

Imatinib Responsiveness in Canine Mast Cell Tumors Carrying Novel Mutations of c-KIT Exon 11
por: NAKANO, Yuko, et al.
Publicado: (2013)

Exon 11 homozygous mutations and intron 10/exon 11 junction deletions in the KIT gene are associated with poor prognosis of patients with gastrointestinal stromal tumors
por: Shen, Yan‐Ying, et al.
Publicado: (2020)

The KIT Exon 11 Stop Codon Mutation in Gastrointestinal Stromal Tumors: What Is the Clinical Meaning?
por: Michelucci, Angela, et al.
Publicado: (2013)

Mutations in Exons 8 and 11 of c-kit Gene in Canine Subcutaneous Mast Cell Tumors and Their Association with Cell Proliferation
por: Chen, Polly, et al.
Publicado: (2022)

Prognosis and predictive value of KIT exon 11 deletion in GISTs
por: Bachet, J-B, et al.
Publicado: (2009)

Computed tomography texture-based models for predicting KIT exon 11 mutation of gastrointestinal stromal tumors
por: Guo, Chuangen, et al.
Publicado: (2023)

Tumor-targeting Salmonella typhimurium A1-R suppressed an imatinib-resistant gastrointestinal stromal tumor with c-kit exon 11 and 17 mutations
por: Miyake, Kentaro, et al.
Publicado: (2018)

Gastrointestinal stromal tumors: associations between contrast-enhanced CT images and KIT exon 11 gene mutation
por: Liu, Xijiao, et al.
Publicado: (2021)

Mutations in c‐kit Gene Exons 9 and 13 in Gastrointestinal Stromal Tumors among Japanese
por: Sakurai, Shinji, et al.
Publicado: (2001)

No detection of c-kit gene mutations in exons 9, 11, 13 and 17 and low CD117 expression in plaque-stage mycosis fungoides
por: Luca, David Aldo De, et al.
Publicado: (2018)

Metabolic response by FDG-PET to imatinib correlates with exon 11 KIT mutation and predicts outcome in patients with mucosal melanoma
por: Zukotynski, Katherine, et al.
Publicado: (2014)

Whole-genome and Epigenomic Landscapes of Malignant Gastrointestinal Stromal Tumors Harboring KIT Exon 11 557–558 Deletion Mutations
por: Ohshima, Keiichi, et al.
Publicado: (2023)

Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: a retrospective analysis
por: Vincenzi, Bruno, et al.
Publicado: (2015)

Prognostic Relevance of SFRP1 Gene Promoter Methylation in Colorectal Carcinoma
por: Kumar, Alok, et al.
Publicado: (2019)

Significance of KIT exon 17 mutation depends on mutant level rather than positivity in core-binding factor acute myeloid leukemia
por: Jang, W, et al.
Publicado: (2016)

A V530I Mutation in c-KIT Exon 10 Is Associated to Imatinib Response in Extraabdominal Aggressive Fibromatosis
por: Kurtz, Jean-Emmanuel, et al.
Publicado: (2010)

Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery
por: Gouda, Mohamed A., et al.
Publicado: (2023)

Molecular landscape and clinical significance of exon 11 mutations in KIT gene among patients with gastrointestinal stromal tumor: a retrospective exploratory study
por: Zhao, Ruihua, et al.
Publicado: (2023)

The Relevance of CD117-Immunocytochemistry Staining Patterns to Mutational Exon-11 in c-kit Detected by PCR from Fine-Needle Aspirated Canine Mast Cell Tumor Cells
por: Sailasuta, A., et al.
Publicado: (2014)

Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs)
por: Incorvaia, Lorena, et al.
Publicado: (2021)

A single digital droplet PCR assay to detect multiple KIT exon 11 mutations in tumor and plasma from patients with gastrointestinal stromal tumors
por: Boonstra, Pieter A., et al.
Publicado: (2018)

BRCA1 c.68_69delAG (exon2), c.181T>G (exon5), c.798_799delTT and 943ins10 (exon11) mutations in Burkina Faso
por: Zoure, Abdou Azaque, et al.
Publicado: (2018)

Imatinib response of gastrointestinal stromal tumor patients with germline mutation on KIT exon 13: A family report
por: Engin, Gulgun, et al.
Publicado: (2017)

Dysgerminoma with a Somatic Exon 17 KIT Mutation and SHH Pathway Activation in a Girl with Turner Syndrome
por: Gawrychowska, Ada, et al.
Publicado: (2020)

Antitumor activity of sorafenib and imatinib in a patient with thymic carcinoma harboring c-KIT exon 13 missense mutation K642E
por: Catania, Chiara, et al.
Publicado: (2014)

Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas
por: Satzger, I, et al.
Publicado: (2008)

Two Case Reports of Rare BRAF Mutations in Exon 11 and Exon 15 with Discussion of Potential Treatment Options
por: Richtig, Georg, et al.
Publicado: (2016)

A novel melting curve-based method for detecting c-kit mutations in acute myeloid leukemia
por: LU, QUANYI, et al.
Publicado: (2014)

KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcome
por: Brahmi, Mehdi, et al.
Publicado: (2015)

Detection of KIT mutations in core binding factor acute myeloid leukemia
por: Badr, Passant, et al.
Publicado: (2018)

Association of MTHFR (C677T) Gene Polymorphism With Breast Cancer in North India
por: Waseem, Mohammad, et al.
Publicado: (2016)

SKP2 High Expression, KIT Exon 11 Deletions, and Gastrointestinal Bleeding as Predictors of Poor Prognosis in Primary Gastrointestinal Stromal Tumors
por: Lv, Ang, et al.
Publicado: (2013)

Two novel mutations in exon 2 of bone morphogenetic protein (BMP) 15 gene in Pakistani infertile females
por: Faiza, Hafiza, et al.
Publicado: (2021)

Novel mutation in exon11 of PRKCG (SCA14): A case report
por: Sun, Rong, et al.
Publicado: (2023)

A Peptide Vaccine Design Targeting KIT Mutations in Acute Myeloid Leukemia
por: Kim, Minji, et al.
Publicado: (2023)

Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature
por: Alvarez-Twose, Iván, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1tsp9lt6te9pbcuihft6lp4ehs